Browsing by Author Thanyanan Reungwetwattana

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
29-Apr-2021Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter StudyKrittiya Korphaisarn; Pongwut Danchaivijitr; Thanyanan Reungwetwattana; Busayamas Chewaskulyong; Luangyot Thongthieang; Jarin Chindaprasirt; Kunlatida Maneenil; Chirawadee Sathitruangsak; Chanida Vinayanuwattikun
31-Mar-2021Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-AnalysisSongporn Oranratnachai; Sasivimol Rattanasiri; Anantaporn Pooprasert; Amarit Tansawet; Thanyanan Reungwetwattana; John Attia; Ammarin Thakkinstian
1-Jan-2021Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patientsKeatdamrong Janpipatkul; Narumol Trachu; Piyakarn Watcharenwong; Wittaya Panvongsa; Wittawin Worakitchanon; Chanatip Metheetrairut; Songporn Oranratnachai; Thanyanan Reungwetwattana; Arthit Chairoungdua
1-Dec-2022Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancerWoraseth Saifon; Insee Sensorn; Narumol Trachu; Songporn Oranratnachai; Angkana Charoenyingwattana; Chakkaphan Runcharoen; Nanamon Monnamo; Warawut Sukkasem; Pimpin Inchareon; Thitiporn Suwatanapongched; Phichai Chansriwong; Touch Ativitavas; Ravat Panvichian; Wasun Chantratita; Thanyanan Reungwetwattana
1-Jan-2018Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian SubsetByoung Chul Cho; Busayamas Chewaskulyong; Ki Hyeong Lee; Arunee Dechaphunkul; Virote Sriuranpong; Fumio Imamura; Naoyuki Nogami; Takayasu Kurata; Isamu Okamoto; Caicun Zhou; Ying Cheng; Eun Kyung Cho; Pei Jye Voon; Jong Seok Lee; Helen Mann; Matilde Saggese; Thanyanan Reungwetwattana; Suresh S. Ramalingam; Yuichiro Ohe
2-Jan-2020Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLCSuresh S. Ramalingam; Johan Vansteenkiste; David Planchard; Byoung Chul Cho; Jhanelle E. Gray; Yuichiro Ohe; Caicun Zhou; Thanyanan Reungwetwattana; Ying Cheng; Busyamas Chewaskulyong; Riyaz Shah; Manuel Cobo; Ki Hyeong Lee; Parneet Cheema; Marcello Tiseo; Thomas John; Meng Chih Lin; Fumio Imamura; Takayasu Kurata; Alexander Todd; Rachel Hodge; Matilde Saggese; Yuri Rukazenkov; Jean Charles Soria